[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Apogee Therapeutics, Inc. Common Stock
Sentiment: XX%
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
1 Week: XX% -X%
1 Month: XX% +10%
6 Months: XX% -XX%
1 Year: XX% -XX%
1-Year High: XXX% on 2024-10-17
1-Year Low: X% on 2025-01-28
Most Supportive Themes
- Positive Analyst Ratings and Price Targets: (35%) Several analysts have reiterated 'Buy' ratings and provided positive price targets for APGE, contributing to positive sentiment.
- Closing of Public Offering: (25%) The announcement of the closing of a public offering and the exercise of the underwriters' option to purchase additional shares has been met with positive reactions.
- Potential Dupixent Rivalry: (20%) TD Cowen highlighted APGE's eczema drugs as potential rivals to Dupixent, which has generated significant interest.
Most Critical Themes
- Public Offering Concerns: (10%) The public offering, while closed, initially caused a price drop, indicating some investor concern.
- After-Hours Price Drop: (10%) The stock experienced a price decrease after the announcement of the public offering, which may be a concern for some investors.
Network engagement breakdown:
| Network | Positive | % | Neutral | % | Negative | % |
|---|---|---|---|---|---|---|
| X | XXXXX | XX% | XXXXX | XX% | XXX | X% |
| Total | XXXXX | XX% | XXXXX | XX% | XXX | X% |